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Summary  Central  line-associated  bloodstream  infection  (CLABSIs)  is  an  important
healthcare-associated  infection  in  the  critical  care  units.  It  causes  substantial  mor-
bidity,  mortality  and  incurs  high  costs.  The  use  of  central  venous  line  (CVL)  insertion
bundle  has  been  shown  to  decrease  the  incidence  of  CLABSIs.
Our  aim  was  to  study  the  impact  of  CVL  insertion  bundle  on  incidence  of  CLABSI
and  study  the  causative  microbial  agents  in  an  intensive  care  unit  in  Kuwait.
Surveillance  for  CLABSI  was  conducted  by  trained  infection  control  team  using
National  Health  Safety  Network  (NHSN)  case  deﬁnitions  and  device  days  measure-
ment  methods.  During  the  intervention  period,  nursing  staff  used  central  line  care
bundle  consisting  of  (1)  hand  hygiene  by  inserter  (2)  maximal  barrier  precautions
upon  insertion  by  the  physician  inserting  the  catheter  and  sterile  drape  from  head
to  toe  to  the  patient  (3)  use  of  a  2%  chlorohexidine  gluconate  (CHG)  in  70%  ethanol
scrub  for  the  insertion  site  (4)  optimum  catheter  site  selection.  (5)  Examination  of
the  daily  necessity  of  the  central  line.During  the  pre-intervention  period,  there  were  5367  documented  catheter-days
and  80  CLABSIs,  for  an  incidence  density  of  14.9  CLABSIs  per  1000  catheter-days.
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After  implementation  of  the  interventions,  there  were  5052  catheter-days  and  56
CLABSIs,  for  an  incidence  density  of  11.08  per  1000  catheter-days.  The  reduction  in
the  CLABSI/1000  catheter  days  was  not  statistically  signiﬁcant  (P  =  0.0859).
This  study  demonstrates  that  implementation  of  a  central  venous  catheter  post-
insertion  care  bundle  was  associated  with  a  reduction  in  CLABSI  in  an  intensive  care
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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The  study  was  conducted  between  January  2010
and February  2012  in  the  main  ICU  of  a  generalarea  setting.
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entral  venous  catheters  (CVCs)  are  increasingly
sed in  inpatient  and  outpatient  settings  to
rovide  long-term  venous  access.  CVCs  disrupt  the
ntegrity of  the  skin,  leading  to  bacterial  and/or
ungal infections.  Infection  may  spread  to  the
loodstream  (bacteremia)  with  the  possibility  of
onsequent  hemodynamic  changes  and  organ  dys-
unction (severe  sepsis),  leading  to  death.
Approximately  90%  of  catheter-related  blood-
tream infections  (CRBSIs)  occur  with  CVCs  [1].
orty-eight  percent  of  intensive  care  unit  (ICU)
atients have  CVCs,  accounting  for  15  million
entral venous  catheter-days  per  year  in  ICUs.
tudies of  catheter-related  bloodstream  infections
CRBSIs)  suggest  that  they  are  among  the  most
ommon healthcare-associated  infections  (HAI)  and
hat they  appear  to  control  the  underlying  sever-
ty of  the  illness  [2].  A  report  in  2013  by  the
enter for  Disease  Control  and  Prevention  (CDC)
ational Health  Safety  Network  (NHSN)  indicates
hat CRBSI  in  ICUs  ranges  between  0.9  and  2.4
mean 1.1)  per  1000  catheter  days  in  major  teach-
ng medical/surgical  ICUs,  which  matches  our  ICU
lassiﬁcation  [3].  The  pooled  rate  of  CLABSI  that
as reported  by  the  International  Nosocomial
nfection Control  Consortium  (INICC)  is  4.9/1000
atheter days  according  to  their  2014  report.  This
s nearly  5-fold  higher  than  the  rate  reported  from
omparable  US  ICUs  that  was  included  in  their
ast report.  The  INICC  study  was  conducted  from
anuary  2007  to  December  2012  in  503  inten-
ive care  units  in  Latin  America,  Asia,  Africa,  and
urope.  Using  the  Center  for  Disease  Control  and
revention’s  (CDC)  U.S.  National  Healthcare  Safety
etwork  (NHSN)  deﬁnitions  for  device-associated
ealth care-associated  infections,  the  authors  col-
ected data  from  605,310  patients  who  were
ospitalized in  ICUs  over  3,338,396  days  [4].  Other
tudies  have  reported  signiﬁcant  increases  in  the
ttributable  mortality  for  these  infections  [5,6]  as
t
a
Uell  as  remarkable  increases  in  the  hospital  length
f stay  and  hospital  cost  [7,8]. It  has  been  estimated
hat between  500  and  4000  US  patients  die  annually
ecause  of  bloodstream  infections  [9].
According  to  Eggimann  et  al.  [10], a compre-
ensive infection  control  program  including  the
eticulous  sterile  insertion  technique  and  post-
nsertion  care  was  associated  with  a  67%  reduction
n CLABSI  incidence  at  a single  center.  In sup-
ort of  the  5  Million  Lives  campaign  in  the  US,
he Institute  for  Healthcare  Improvement  (IHI)
http://www.ihi.org/ihi) recommends  that  all  ICUs
hould implement  a central  line  bundle  in  an
ttempt to  reduce  the  incidence  of  CLABSI  to  zero
11]. The  concept  of  ‘‘bundles’’  that  was  developed
y the  IHI  was  to  help  healthcare  providers  more
eliably deliver  the  best  possible  care  for  patients
ndergoing  particular  treatments  with  inherent
isks. A  bundle  is  a structured  method  of  improv-
ng the  processes  of  care  and  patient  outcomes:
 small,  straightforward  set  of  evidence-based
ractices—–generally  three  to  ﬁve—–that,  when  per-
ormed collectively  and  reliably,  have  been  proven
o improve  patient  outcomes  [12]. The  science
upporting the  bundle  components  is  sufﬁciently
stablished to  be  considered  the  standard  of  care.
The purpose  of  this  study  was  to  evaluate  the
ffectiveness of  a ‘‘Central  Venous  Line  bundle’’
CVLB) implementation  in  our  main  ICU  on  the
utcome  of  CLABSI  and  to  establish  the  causative
icroorganisms.
ubjects and methods
ettingeaching hospital,  a  Ministry  Of  Health-run  hospital
fﬁliated  with  the  Health  Sciences  Center  of  Kuwait
niversity.  The  adult  medical—surgical  ICU  consists
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of  2  wings  with  a  capacity  of  23  beds  that  are  struc-
turally  identical  and  an  occupancy  rate  of  100%  at
all times.  It  operates  an  open-stafﬁng  model  with  3
beds in  isolation  rooms  in  each  wing.  Because  this
was considered  to  be  a  quality  improvement  study,
we did  not  submit  it  for  ethical  approval  by  the
Ministry of  Health.
Design
This  is  a  26-month  prospective  cohort  study  that
was conducted  in  2  phases,  a  pre-intervention
period to  establish  base-line  total  HCAI  and  CLABSI
from January  2010  to  January  2011  and  a  post-
interventional period  to  measure  HCAI  and  CLABSI
from February  2011  to  February  2012.  The  rates
of HCAI  and  CLABSI  were  calculated  per  1000
patient days  and  central  line  days,  respectively.
Patients fulﬁlling  the  criteria  of  the  deﬁnition  of
HCAI were  included  in  our  study  to  calculate  the
total rate/1000  patient  days,  and  from  these,  our
focus was  on  patients  with  CLABSI  to  calculate  the
rate/1000  CVC  days  in  both  intervals.
Surveillance program
Infection  surveillance  was  implemented  for  all
patients  who  were  admitted  to  the  ICU  with  a stay
longer  than  48  h  during  the  period  from  January  1,
2010, to  February  29,  2012.  The  Center  for  Disease
Control and  Prevention  (CDC)  deﬁnitions  of  nosoco-
mial infections  [13]  and  the  standard  surveillance
methods of  the  National  Health  Safety  Network
(NHSN) were  used,  as  previously  described  [14].  The
infection control  team  performed  surveillance  that
involved ICU  daily  rounds,  microbiology  reviews  and
chart reviews.  Kuwait  National  Health  Surveillance
System (KNHSS)  worksheets  were  used.  The  fol-
lowing  data  were  collected:  patient’s  name,  ﬁle
number, age,  nationality,  bed  number,  admission
date, diagnosis,  duration  of  ICU  stay,  duration  that
the catheter  was  in  place,  and  the  isolated  organ-
ism(s)  from  blood.  CLABSI  is  a  laboratory-conﬁrmed
bloodstream  infection  (LCBI)  where  the  central  line
(CL) was  in  place  for  >2  calendar  days  on  the  date  of
the event,  with  the  day  of  device  placement  being
Day 1,  and  the  CL  was  in  place  on  the  date  of  the
event or  the  day  before.  The  CLABSI  rate  was  cal-
culated  as  the  number  of  all  CLABSI  per  1000  CVC
days.
The number  of  patients  with  one  or  more  cen-
tral lines  of  any  type  was  collected  daily  and
was summed  to  calculate  the  number  of  catheter-
days for  each  period  of  analysis.  The  catheter
dwell time  was  deﬁned  as  the  number  of  days
between catheter  insertion  and  the  onset  of  CLABSI
e
t
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ymptoms.  If  a patient  had  a catheter  in  situ  on
he day  of  admission,  that  date  was  used  as  the
nsertion  date.  The  catheter  utilization  proportion
as calculated  by  dividing  the  number  of  catheter
ays  by  the  number  of  patient-days  for  each  time
eriod.
Surveillance  was  conducted  by  a  well-trained
nfection control  team.  They  reviewed  the  med-
cal record  of  every  patient  who  had  a  positive
lood culture  by  using  a  standard  data  collection
orm. Each  case  was  then  reviewed  by  the  Infec-
ion Control  Physician  to  ensure  that  it  met  the
ase deﬁnition.  The  reporting  of  all  bloodstream
nfections was  performed  per  1000  patient  catheter
ays.
icrobial identiﬁcation
acteria  were  cultured  using  standard  microbiolog-
cal methods.  They  were  identiﬁed  by  conventional
ethods according  to  the  Kirby-Bauer  disk  diffu-
ion technique  and  the  VITEK  2  system  (bioMérieux,
arcy, l’Etoile,  France).  The  results  of  antibi-
tic susceptibility  testing  for  the  isolated  microbes
ausing  CLABSI  were  interpreted  according  to
he recommendations  of  the  Clinical  Laboratory
tandard Institute  (CLSI)  [15,16].
VC bundle of care
 CVC  insertion  bundle  was  implemented  in
ebruary 2011  in  the  main  ICU;  the  bundle  inser-
ion procedure  consisted  of  (1)  hand  hygiene  by  the
nserter; (2)  maximum  barrier  precautions,  includ-
ng the  donning  of  sterile  gloves,  gowns,  caps  and
asks  by  the  physicians  who  inserted  the  catheter
efore  beginning  the  procedure  and  a head-to-
oe sterile  drape  of  the  patient  during  insertion;
3) use  of  a 2%  chlorhexidine  gluconate  (CHG)  in
0% ethanol  scrub  at  the  insertion  site;  (4)  opti-
al catheter  site  selection  with  avoidance  of  the
emoral  vein  for  central  venous  access  in  adult
atients; and  (5)  daily  examination  of  the  necessity
f the  central  line.  Physicians  were  trained  in  the
septic technique  for  CVC  insertion  by  presenta-
ions that  were  carried  out  by  the  infection  control
eam  at  the  beginning  of  the  rotation.  Nursing  staff
ere empowered  to  halt  the  procedure  if  a  break
n sterile  technique  was  observed,  and  they  were
asked  with  monitoring  compliance  with  the  inser-
ion bundle.  For  recording  overall  compliance  for
he central  line,  it  was  ‘‘ALL  OR  NONE’’,  that  is,
ven if  one  element  of  the  bundle  was  missing  on
he day  of  inspection,  the  case  would  not  be  in
ompliance with  the  bundle.  The  central  lines  were
heck, but  not  the  patients.  In  addition,  the  central
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Table  1  Characteristics  of  patients  with  CLABSI  comparing  pre-intervention  and  post-intervention  periods.
Patient  characteristics  Before  intervention  After  intervention  P  value
Mean  length  of  stay  31.78  41.39  0.02523
Male  (%)  66.25  53.57  0.135669
Mean  age  57.9  59.16  0.687256
Percentage  of  deaths  20  17.86  0.628929
Site  of  central  venous  catheter  0.015037
Internal  Jugular 50  24
Subclavian  31  39
Femoral  7  8
Days’  duration  of  CVC  30.025  40.16  0.013849
CLABSI, central line associated bloodstream infection; CVC, central vascular catheter.
nsert
e bun
l
I
t
t
C
C
C
w
t
t
c
e
c
 co
ed  
S
D
I
f
f
K
w
t
m

n
o
t
c
t
n
d
s
R
T
t
r
a
t
t
l
d
C
o
t
t
d
t
d
a
i
2
p
o
d
t
s
c
s
c
c
rThe entries in bold correspond to the mean duration of CVC i
signiﬁcant lower duration of catheter insertion period after th
ine  days  rather  than  patients  were  counted.  The
nfection  Control  Team  entered  the  main  ICU  three
imes per  week  to  spot-check  all  patients  with  cen-
ral lines  and  assess  them  for  compliance  with  the
VLB.
ompliance measurement calculations
ompliance  with  each  individual  bundle  element
as calculated  with  a  special  form  by  dividing  the
otal number  of  patient  central  line  days  compliant
o the  given  element  by  the  total  number  of  patient
entral  line  days  examined  for  compliance  with  the
lement (%).  Total  CVL  bundle  compliance  was  also
alculated  using  the  following  equation:
Total  number  of  patient-days  compliant  with
Total  number  of  patient  catheter-days  examin
tatistical methodology
ata  were  collected,  coded  and  entered  into  an
BM compatible  computer,  using  SPSS  version  19
or Windows.  The  entered  data  were  checked
or accuracy  and  then  for  normality  using  the
olmogorov—Smirnov  test.  Qualitative  variables
ere expressed  as  a  number  and  percentage,  while
he quantitative  variables  were  expressed  as  the
ean (X)  and  standard  deviation  (S).
The following  statistical  tests  were  used:  (1)  The
2-test  was  used  as  a  non-parametric  test  of  sig-
iﬁcance  for  comparison  between  the  distribution
f two  qualitative  variables  and  (2)  Fisher’s  exact
est was  used  as  a  non-parametric  test  of  signiﬁ-
ance for  comparison  between  the  distribution  of
wo qualitative  variables  whenever  the  2-test  was
ot appropriate.  Fisher’s  exact  test  gives  a  P-value
irectly.  A  5%  level  was  chosen  as  being  statistically
igniﬁcant.
i
p
w
Cion in days in the pre and post intervention periods, showing
dle implementation.
mbined  5  central  line  bundle  ×  100
for  combined  5  central  line  bundle
esults
he  characteristics  of  patients  with  CLABSI  during
he pre-  and  post-intervention  periods  re  summa-
ized in  Table  1. There  was  no  signiﬁcant  difference
mong the  studied  criteria  among  patients  in  both
he pre-  and  post-intervention  periods,  except  for
he duration  of  catheter  insertion  and  the  mean
ength of  stay,  which  were  signiﬁcantly  increased
uring the  pre-intervention  period  (Table  1).
Compliance with  the  different  elements  of  the
VL insertion  bundle  showed  ﬂuctuation  through-
ut the  period  of  observation  (Table  2).  During
he pre-intervention  period  from  January  1,  2010,
o  January  31,  2011,  there  were  7161  patient-
ays and  5367  documented  catheter-days,  with  a
otal of  80  reported  CLABSI  episodes,  for  an  inci-
ence density  of  14.9  CLABSIs/1000  catheter  days
nd a catheter  utilization  proportion  of  0.75.  After
mplementation  of  the  interventions  (February  1,
011 to  February  29,  2012),  there  were  6474
atient-days and  5052  catheter-days  with  a total
f 56  reported  CLABSI  episodes  for  an  incidence
ensity of  11.08  per  1000  catheter  days.  The  reduc-
ion in  the  CLABSI/1000  catheter  days  was  not
tatistically  signiﬁcant  (P  = 0.0859)  (Table  3).  The
atheter  utilization  proportion  was  0.79.  In  this
tudy, the  number  of  reported  episodes  of  health
are-associated  CLABSI  was  equal  to  that  of  the
ausative  microorganisms  (Table  4).  There  was  a
eported decrease  in  Gram-negative  microorgan-
sms causing  CLABSI  during  the  post-intervention
eriod (except  for  Stenotrophomonas  maltophilia),
hich were  not  frequently  isolated  even  before  the
VL bundle  implementation  (Table  4).
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Table  2  Central  venous  line  bundle  compliance  rates  (%)  from  February  2011-February  2012  in  the  main  intensive  care  unit.
Bundle  element Compliance  rates  (%)  in  the  month  of
February
2011
March
2011
April
2011
May
2011
June
2011
July
2011
August
2011
September
2011
October
2011
November
2011
December
2011
January
2012
February
2012
Total  central  line
days
108  169  80  136  137  139  131  145  158  92  110  127  96
1.  Hand  hygiene
by  inserter
94.44 80.47% 97.5% 91.91% 97.08% 99.28% 92.36% 97.93 97.46  100  100  100  95.83
2.  Maximal
barrier
precautions
upon  insertion
92.59 75.73% 83.75% 77.20% 85.40% 92.08%  92.36%  94.48  98.10  90.21  84.54  98.42  92.7
3.  Chlorhexidine
(2%  in  70%
isopropyl
alcohol)  skin
antisepsis  upon
insertion
73.14% 76.33%  97.5%  91.91%  97.08%  99.28%  92.36%  97.93  100  100  98.18  98.42  88.54
4.  Optimal
catheter  site
selection  (with
avoidance  of
the  femoral
vein  for  central
venous  access
in  adult
patients)
91.66% 79.28%  83.75%  83.08%  90.51%  98.56%  92.36%  95.86  96.83  97.82  100  100  97.91
5.  Daily  review  of
line  necessity
with  prompt
removal  of
unnecessary
lines
83.33% 67.45%  83.75%  73.52%  88.32%  92.08%  89.31%  95.17  95.56  97.82  95.45  94.48  98.95
Total  61.11%  57.39%  66.25%  51.47%  71.53%  84.17%  82.44%  92.41  89.87  90.21  80.9  91.33  77.08
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Table  3  CLABSI  rates  in  the  main  intensive  care  unit  before  and  after  implementation  of  bundles.
Infection  Before  intervention  After  intervention  P  value
CLABSI/1000  CVL  days  14.9  11.08  0.0859
Central  line  days  5367  5052  0.339554
Patients’  days  7161  6474  0.08261
HCAI, healthcare associated infection; CLABSI, central line associat
Discussion
The  implementation  of  CVL  bundles  of  care  was  ini-
tiated in  our  main  ICU  in  February  2011  as  a  measure
for healthcare  improvement.  Compliance  with  the
CVL bundle  elements  showed  ﬂuctuations  through-
out the  period  of  observation  and  was  attributed
to periods  of  low  nurse:  patient  ratios,  result-
ing in  a  lack  of  compliance.  The  noticeable  low
compliance  with  the  CVLB  during  March,  April  and
May 2011  coincided  with  periods  of  reported  high
CLABSI/1000  catheter  days  of  18.04,  14.07,  16.85,
respectively.
Chlorhexidine  gluconate  (2%  in  70%  isopropyl
alcohol) was  used  for  skin  antisepsis  upon  inser-
tion of  central  line  catheters  instead  of  povidone
iodine, which  was  used  in  other  areas  of  the  hospi-
tal where  the  CVL  bundle  was  not  yet  implemented.
Our ﬁndings  demonstrate  that  implementation  of
Table  4  Microorganisms  implicated  in  central  line
associated  bloodstream  infection  in  the  main  intensive
care  unit  before  and  after  implementation  of  bundles.
Microorganism  Before
intervention
After
intervention
Klebsiella
pneumoniae
12 8
Acinetobacter
baumannii
14  10
P.  aeruginosa  21  14
E.  coli  5  2
Enterococcus
faecalis
4 1
Candida  spp.  4  3
S.  epidermidis  3  5
Proteus  mirabilis  3  1
MRSA  2  1
Stenotrophomonas
maltophilia
4 5
Serratia  marcescens  4  2
Enterobacter
cloacae
4 3
Citrobacter  koserii  1
Total  CLABSI 80  56
P value 0.081206.
CLABSI, central line associated bloodstream infection.
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 CVL  insertion  care  bundle  was  associated  with  a
ecrease in  the  total  CLABSI/1000  central  line  days
rom 14.9  to  11.08  infections;  however,  the  differ-
nce was  not  statistically  signiﬁcant  (P  =  0.0859).
t is  important  to  note  that  during  the  month  of
une 2011,  no  healthcare  associated  CABSI  were
eported;  this  could  be  attributed  to  the  period
ollowing the  introduction  of  hand  hygiene  obser-
ational and  educational  campaigns  that  were
onducted  in  May  2011  [17]. One  study  conducted
y Rosenthal  el  al.  addressed  that  the  educa-
ion, performance  feedback,  and  outcome  and
rocess  surveillance  of  CLABSI  rates  signiﬁcantly
mproved infection  control  adherence,  reducing  the
LABSI incidence  by  54%  and  the  number  of  CLABSI-
ssociated  deaths  by  58%  in  INICC  hospitals  during
he ﬁrst  2  years  [18].
The number  of  CLABSIs  in  our  ICU  that
ere caused  by  multidrug-resistant  (MDR)  orga-
isms decreased  from  80  organisms  in  the
re-implementation  period  to  56  in  the  post-
mplementation period  with  CVL  bundles  of  care;
his ﬁnding  is  in  agreement  with  a  previous
tudy that  showed  that  the  overall  infection  rates
ecreased  with  an  improvement  in  CRBSIs  in  all  of
he ICUs  that  participated  [19].  Although  the  pro-
ortion of  Gram-negative  organisms  did  not  change
igniﬁcantly  in  that  study,  there  was  a  signiﬁ-
ant decrease  in  the  proportion  of  Gram-positive
nfections  [19]. In  a  study  similar  to  ours,  9938
entral line  days  were  included  from  a total  of
395 central  venous  catheters,  demonstrating  that
he average  number  of  CLABSI  per  1000  catheter
ays decreased  from  5.0  to  0.90  (P  <  .001)  after
he initiation  of  CVC  bundle  intervention  [20].
urther studies  that  were  considered  to  be  mul-
imodal, multidisciplinary,  hospital-wide  training
trategies  in  successfully  reducing  CLABSI  suggested
hat a  clinically  relevant  reduction  of  hospital-wide
LABSI was  reached  with  a  comprehensive,  multi-
isciplinary  and  multimodal  quality  improvement
rogram including  aspects  of  behavioral  change
nd key  principles  of  good  implementation  practice
21,22].
However,  our  results  were  somewhat  differ-
nt from  those  in  the  study  conducted  by  Guerin
t al.  [23],  which  demonstrated  a  signiﬁcant
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association  between  the  implementation  of  a  CVC
post-insertion  care  bundle  and  a  reduction  in
CLABSI. We  achieved  the  same  type  of  noticeable
decrease in  CLABSI  that  was  demonstrated  by  this
group, who  reported  an  incidence  density  of  5.7
CLABSIs  per  1000  catheter-days  pre-intervention
and 3  CLABSIs,  for  an  incidence  density  of  1.1  per
1000 catheter-days  after  implementation  of  the
interventions.
In the  main  ICU  of  our  hospital,  CLABSI  are  among
the most  commonly  reported  healthcare  associated
infections (HCAI),  accounting  for  34.1%,  and  42.3%
of the  total  HCAI  reported  in  2010  and  2011,  respec-
tively. Our  surveillance  data  indicated  an  ongoing
high incidence  density  of  CLABSI  in  relation  to  the
HCAI from  other  sites  that  led  us  to  review  each
case for  clues  regarding  the  underlying  reason  for
the high  incidence.  We  found  no  commonalities  in
physician  staff,  services,  admission  diagnoses,  or
pathogens.  We  noted  that  the  median  in  situ  time
between  catheter  insertion  and  onset  of  infection
was 14  days,  which  led  us  to  suspect  that  events
occurring after  insertion  might  be  responsible  for
the infections.
Compliance  with  sterile  technique  at  the  time
of CVL  insertion  was  not  sufﬁcient  by  itself  to  pre-
vent CLABSI  because  the  insertion  of  a  CVC  results
in the  ongoing  presence  of  a  foreign  body  travers-
ing the  cutaneous  barrier.  Part  of  the  limitations  of
this study  was  that  meticulous  post-insertion  site
care to  prevent  CLABSI  was  not  included  in  this
study. As  we  carried  out  staff  education  and  rein-
forcement  of  proper  CVL  care  after  insertion,  along
with careful  cleaning  of  the  hub  before  each  access,
this might  have  contributed,  in  part,  to  the  reduc-
tion in  infection  incidence  that  was  noted  in  our
study.  The  elements  of  post-insertion  care,  includ-
ing hand  hygiene,  chlorhexidine  for  site  cleansing
[24],  chlorhexidine-impregnated  sponges  [25]  and
attention to  decontamination  of  access  ports  with
each use  [26],  were  reinforced  in  our  hospital.  In
spite of  these  post-insertion  care  measures,  the
results of  our  study  showed  a  non-signiﬁcant  reduc-
tion in  the  total  reported  CLABSI  before  and  after
CVL bundle  implementation,  which  suggests  that
reducing  the  CLABSI  rates  in  an  ICU  setting  is  a  com-
plex process  that  probably  involves  other  factors
in addition  to  CVL  bundle  implementation  alone.
This should  be  an  area  for  further  research  in  the
future when  we  will  start  the  implementation  of
catheter  maintenance  bundles  of  care  in  addition
to the  currently  implemented  insertion  bundle.  This
study was  also  limited  by  the  absence  of  data  with
regards to  the  extra  costs  that  were  attributable  to
CLABSI in  addition  to  the  inclusion  of  a  single  adult
ICU.M.F.  Salama  et  al.
onclusion
LABSI  are  expensive,  common,  and  potentially
atal. Reduction  in  the  CLABSI  rate  at  our  institu-
ion coincided  with  the  implementation  of  the  CVL
undle.  Our  current  series  demonstrates  a notewor-
hy decrease,  albeit  a non-statistically  signiﬁcant
ecrease, in  the  rate  of  CLABSI,  a beneﬁt  that  was
ustained  throughout  the  study.  From  our  study,  it
an be  inferred  that  the  broad  use  of  CVLB  will
igniﬁcantly reduce  the  cost  and  morbidity  of  CLAB-
Is; thus,  the  adoption  of  CVLB  nationwide  is  highly
ecommended.
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